Refractory Hepatic Encephalopathy: Clinical Trials

2 trials for Refractory Hepatic Encephalopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 withdrawn. 1 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1
Not applicable1Withdrawn 1

Follow Refractory Hepatic Encephalopathy: new trials by email Literature Review of Refractory Hepatic Encephalopathy trials Research Report on Refractory Hepatic Encephalopathy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fecal Microbiota Transplantation for the Treatment of Refractory Hepatic Encephalopathy After TIPS Surgery
Fecal Microbiota Transplantation, Rifaximin、Lactulose, Dietary Fiber Prebiotic - Hepatic Encephalopathy, Fecal Microbiota Transplantation
Early Phase 1RecruitingAir Force Military Medical University, China262026-06-012026-07-06
High Volume Plasmapheresis for Refractory Hepatic Encephalopathy in Liver Intensive Care Unit.
Lactulose, Rifaximin, Plasmapheresis - Refractory Hepatic Encephalopathy
Not applicableWithdrawnInstitute of Liver and Biliary Sciences, India2018-04-072019-11-04

Narrower conditions

Hepatic Encephalopathy (2)

Broader conditions

Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Central Nervous System Diseases (2)  ·  Digestive System Diseases (2)  ·  Hepatic Insufficiency (2)  ·  Liver Diseases (2)  ·  Liver Failure (2)  ·  Metabolic Diseases (2)  ·  Nervous System Diseases (2)  ·  Nutritional and Metabolic Diseases (2)

Interventions

Fecal Microbiota Transplantation (1)  ·  Lactulose (1)  ·  Plasmapheresis (1)  ·  Rifaximin (1)

Sponsors

Air Force Military Medical University, China (1)  ·  Institute of Liver and Biliary Sciences, India (1)

Countries

China (1)  ·  India (1)

Top investigators

Jing LI (1)

Results publications

PMID 35313729